NYSTAFORM Drug Patent Profile
✉ Email this page to a colleague
When do Nystaform patents expire, and when can generic versions of Nystaform launch?
Nystaform is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in NYSTAFORM is clioquinol; nystatin. There is one drug master file entry for this compound. Additional details are available on the clioquinol; nystatin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NYSTAFORM?
- What are the global sales for NYSTAFORM?
- What is Average Wholesale Price for NYSTAFORM?
Summary for NYSTAFORM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| DailyMed Link: | NYSTAFORM at DailyMed |
US Patents and Regulatory Information for NYSTAFORM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | NYSTAFORM | clioquinol; nystatin | OINTMENT;TOPICAL | 050235-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
